ArticleThe Journal of international medical research2022

Time to switch angiotensin-converting enzyme inhibitors/angiotensin receptor blockers to sacubitril/valsartan in patients with cancer therapy-related cardiac dysfunction.

Qianlan Xi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.